Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells

Author:

Fan Wei123,Yang Heping1,Liu Ting4,Wang Jiaohong1,Li Tony W.H.1,Mavila Nirmala1,Tang Yuanyuan15ORCID,Yang JinWon1,Peng Hui1,Tu Jian16,Annamalai Alagappan7,Noureddin Mazen17,Krishnan Anuradha8,Gores Gregory J.8,Martínez-Chantar Maria L.9,Mato José M.9,Lu Shelly C.1

Affiliation:

1. Division of Digestive and Liver Diseases; Cedars-Sinai Medical Center; Los Angeles CA

2. Department of Geriatrics; Guangzhou First People's Hospital; Guangzhou China

3. State Key Laboratory of Respiratory Diseases, First Affiliated Hospital, Guangzhou Medical University; Guangzhou China

4. Department of Gastroenterology; Xiangya Hospital, Central South University; Changsha Hunan China

5. Department of Oncology; Second Xiangya Hospital, Central South University; Changsha Hunan China

6. Institute of Pharmacy & Pharmacology; University of South China; Hengyang China

7. Comprehensive Transplant Center; Cedars-Sinai Medical Center; Los Angeles CA

8. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN

9. CIC bioGUNE; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Technology, Park of Bizkaia; Bizkaia Spain

Funder

National Institutes of Health

Plan Nacional of I+D SAF

Departmento de Educación del Gobierno Vasco

Publisher

Wiley

Subject

Hepatology

Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3